Endothelin system expression in the kidney following cisplatin-induced acute kidney injury in male and female mice.
Anabelle GalesSureena Monteiro-PaiKelly A HyndmanPublished in: Canadian journal of physiology and pharmacology (2022)
The chemotherapeutic agent cisplatin accumulates in the kidney and induces acute kidney injury (AKI). Preclinical and clinical studies suggest that young female mice and women show greater recovery from cisplatin-AKI compared to young male mice and men. The endothelin (ET) and ET receptors are enriched in the kidney and may be dysfunctional in cisplatin-AKI; however, there is a gap in our knowledge about the putative effects of sex and cisplatin on the renal ET system. We hypothesized that cisplatin-AKI male and female mice will have increased expression of the renal ET system. As expected, all cisplatin-AKI mice had kidney damage and body weight loss greater than control mice. Cisplatin-AKI mice had greater cortical Edn1, Edn3, Ednra , and Ednrb , while outer medullary Ednra was significantly suppressed in both sexes. Of the ∼25 000 genes sequenced from the inner medulla, only 91 genes (comparing saline mice) and 134 genes (comparing cisplatin-AKI mice) were differentially expressed and they were unrelated to the ET system. However, Edn1 was significantly greater in the inner medulla of male and female cisplatin-AKI mice. Thus, RNA profiles of the ET system were significantly affected by cisplatin-AKI throughout the kidney regardless of sex and this may help determine the therapeutic potential of targeting the ET receptors in cisplatin-AKI.
Keyphrases
- acute kidney injury
- high fat diet induced
- cardiac surgery
- weight loss
- poor prognosis
- oxidative stress
- type diabetes
- wild type
- body mass index
- metabolic syndrome
- pregnant women
- middle aged
- adipose tissue
- dna methylation
- skeletal muscle
- bariatric surgery
- drug delivery
- weight gain
- roux en y gastric bypass
- cancer therapy
- polycystic ovary syndrome
- bioinformatics analysis
- genome wide analysis